2) HIV-1 integrase inhibitors
HIV-1整合酶抑制剂
1.
In the paper, the synthesis of sulfonamide arylβ-diketo acids and quinoxalinone derivatives is the aim of our research based on the analysis priminary fact of arylβ-diketo acids HIV-1 integrase inhibitors.
芳基β-二酮酸衍生物是迄今为止所报道的唯一具有细胞内抗病毒活性的HIV-1整合酶抑制剂。
2.
Polydroxylated styrylquinoline derivatives are one of the potential HIV-1 integrase inhibitors with anti-viral activity in cell culture.
苯乙烯喹啉衍生物是目前报道的一类潜在的HIV-1整合酶抑制剂。
3) HIV-1 integrase inhibitor
HIV-1整合酶抑制剂
1.
Progress on diketo acid HIV-1 integrase inhibitors
二酮酸类HIV-1整合酶抑制剂的研究进展
2.
In this article,the important strategies of CADD are summarized;and the applications of CADD in the development of HIV-1 integrase inhibitors and influenza virus neuraminidase inhibitors are particularly introduced.
本文概述了CADD的设计方法,并例举了CADD在HIV-1整合酶抑制剂和感冒病毒神经氨酸酶抑制剂研发中的应用,阐述了CADD在酶抑制剂研究中应用前景。
4) Inhibition of HIV-1 integrase
抑制HIV-1整合酶
6) integrase inhibitors
整合酶抑制剂
1.
In order to develop the HIV integrase inhibitors with high bioactivity、low toxicity and favorable bioavailability, several key DKAs (Diketo acids) integrase inhibitors are introduced to provide academic basis for searching effective anti-HIV medicine according to those medicines widely used in market.
为了开发高效、低毒、生物利用度好的HIV整合酶抑制剂,对几种重要的二酮酸类HIV整合酶抑制剂做了介绍,为寻找新的有效的抗艾滋病药物提供理论依据。
2.
Recent developments and approaches for anti-HIV chemical drugs in clinical trials were re- viewed and analyzed in this manuscript,including new agents of entry inhibitors,reverse transcriptase inhibitors, integrase inhibitors,protease inhibitors,maturation inhibitors,zinc finger inhibitors,and so forth.
综述和分析了目前国内外正在进行的抗HIV化学药物临床试验的进展情况,这些药物包括进入抑制剂、逆转录酶抑制剂、整合酶抑制剂、蛋白酶抑制剂、成熟抑制剂、锌指抑制剂等。
3.
In this review,current five kinds of anti-HIV drugs including nucleotide reverse-transcriptase inhibitors(NRTIs),Non-nucleoside reverse-transcriptase inhibitors(NNRTIs),Protease inhibitors(PIs), Entry Inhibitors(EIs) and integrase inhibitors(IIS) are reported.
笔者全面综述了已上市的五大类抗AIDS药物,包括核苷类逆转录酶抑制剂(NRTIs)、非核苷类逆转录酶抑制剂(NNRTIs)、蛋白酶抑制剂(PIs)、进入抑制剂(entry inhibitors)、整合酶抑制剂(integrase inhibitors)的作用机制、特点及ADR情况,并探讨了一些有可能成为新的抗AIDS药物的研究进展,以期为AIDS的药物治疗提供参考。
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条